Mixed copper(ii)–phenanthroline complexes induce cell death of ovarian cancer cells by evoking the unfolded protein response. Issue 9 (26th July 2019)

• Record Type: Journal Article
• Authors: Moráň, Lukáš; Pivetta, Tiziana; Masuri, Sebastiano; Vašíčková, Kateřina; Walter, Franziska; Prehn, Jochen; Elkalaf, Moustafa; Trnka, Jan; Havel, Josef; Vaňhara, Petr
• Is Part Of: Metallomics. Volume 11:Issue 9(2019)
• Page Start: 1481
• Page End: 1489
• Publication Date: 2019-07-26
• Subjects: Metals -- Physiological effect -- Periodicals; 572.51
• DOI: 10.1039/c9mt00055k
• Languages: English
• ISSNs: 1756-5901

Abstract

Abstract : There is an ongoing need for development of new therapeutics that override acquired resistance to cancer therapy. Targeting endoplasmic reticulum by Cu(ii )–phenanthroline complexes may represent such alternative strategy to current cytotoxic drugs. Abstract : There is an ongoing need for the development of new cancer therapeutics that combine high cytotoxic efficiency with low side effects, and also override resistance to the first-line chemotherapeutics. Copper(ii )–phenanthroline complexes are promising compounds that were shown previously to induce an immediate cytotoxic response over a panel of tumor cell lines in vitro . The molecular mechanism, however, remained unresolved. In this work we performed a thorough study of the copper(ii )–phenanthroline complexes containing different imidazolidine-2-thione ligands in ovarian cancer cells, and revealed that these complexes induce endoplasmic reticulum (ER) stress and subsequently cell death mediated by the unfolded protein response. Alleviation of the ER-stress by tauroursodeoxycholic acid (TUDCA) attenuated the cytotoxic effects. In summary, we have identified a novel, ER-dependent, molecular mechanism mediating cytotoxic effects of copper(ii )–phenanthroline complexes.